Medical Products of Human Origin, UDI and ICCBBA: Supply Chain’s Role Podcast

By AHRMM

Some Human Cellular Tissue Products (HCTP) are considered “devices” and will require their assigned Unique Device Identifiers (UDI) to be tracked within the patient’s Electronic Health Record (EHR) and shared across the healthcare spectrum. Supply chain should be having interdepartmental conversations to determine how they will handle these types of products and their UDIs.

Related Resources

On-Demand Educational Webinars
Closing the Gap: What Can Health Care Learn from Retail
Health care costs continue to rise at an alarming rate, growing well ahead of inflation. In this webinar, we compare and contrast the education and…
On-Demand Educational Webinars
UDI: A How-To Guide for Implementation with Your Organization
This session explains the benefits of implementing the UDI such as immediate device status updates through collaboration with manufacturers and…
e-Learning
PPI Strategies for Success
Webcast
Webcast: What Hospitals Use as a Basis for Decision Making
Brent Petty, executive industry consultant, Healthcare Lexmark International, discusses what forces are currently affecting health care and the pla
Podcasts
The Meaningful Use 3 Rule
A short introduction to the CMS Meaningful Use 3 Rule and how implementing UDI within the healthcare setting and moving toward the full GS1 will re
On-Demand Educational Webinars
The Impact of Supply Chain Processes on O.R. Time, Efficiency, & Overall Cost
Resiliency in the operating room is imperative in today’s health care climate. A well-functioning OR has the potential to increase the number of…